Atlas Trials

HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

Clinical trial NCT04453436 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04453436
Sponsor
Federal University of São Paulo
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
HIVDrugResistance
Start date
2023-09-01
Primary completion
2024-12-31
Enrollment
2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.